Tca.7z

: Drugs are activated by glycosidases produced by local gut bacteria, making the treatment highly site-specific.

: Free Induction Decay data that researchers use to reconstruct the molecular "fingerprint" of the synthetic compounds. Key Highlights of the Study tca.7z

The research focuses on , a targeted drug delivery system. It uses complex plant oligosaccharides (like xyloglucan) to "cage" drugs, ensuring they are only released in the gut by specific bacterial enzymes. This prevents off-target side effects and increases the efficacy of anti-inflammatory treatments for conditions like Inflammatory Bowel Disease (IBD). Why "tca.7z"? : Drugs are activated by glycosidases produced by

: Original Nuclear Magnetic Resonance spectra files used to verify the chemical structure of the drug-linker-carbohydrate complex. It uses complex plant oligosaccharides (like xyloglucan) to

The filename is likely associated with the supplementary data for the research paper "Bespoke plant glycoconjugates for gut microbiota–targeted drug delivery," published in Nature (or hosted on data repositories like Dryad ). Context of the Paper

: By keeping the drug inactive until it reaches the colon, the system eliminates systemic side effects typically seen with steroids or anti-inflammatory drugs.

: The data includes everything from chemical synthesis and enzyme kinetics to murine (mouse) model pharmacokinetics.